Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Proliferative Vitreoretinopathy (PVR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Proliferative Vitreoretinopathy (PVR) (Ophthalmology) pipeline landscape. Proliferative Vitreoretinopathy (PVR) occurs when a scar forms under or on the retina after retinal detachment, preventing the retina from healing and ... Read More
-
Duchenne Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Duchenne Muscular Dystrophy (Genetic Disorders) pipeline landscape. Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscles to gradually weaken over time. Signs and symptoms of DMD ... Read More
-
Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Candidiasis (Infectious Disease) pipeline landscape. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch ... Read More
-
Polycythemia Vera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Polycythemia Vera (Oncology) pipeline landscape. Polycythemia Vera (PV) is a stem cell disorder characterized as a panhyperplastic, malignant and neoplastic marrow disorder. Symptoms include itchiness, headache, dizziness, weakness and excessive ... Read More
-
Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Cough (Respiratory) pipeline landscape. Cough is a reflex action that clears the throat of mucus or foreign irritants. Signs and symptoms include stuffy nose, hoarseness, wheezing and shortness of breath and heartburn ... Read More
-
3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (PDPK1 or EC 2.7.11.1) - 3 Phosphoinositide Dependent Protein Kinase 1 is an enzyme encoded by the PDPK1 gene Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation ... Read More
-
Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Nasopharyngeal Cancer (Oncology) pipeline landscape. Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose. This area is ... Read More
-
Becker Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Becker Muscular Dystrophy (Genetic Disorders) pipeline landscape. Becker muscular dystrophy (BMD) is one of type of muscular dystrophy, a group of genetic, degenerative diseases primarily affecting voluntary muscles. ... Read More
-
Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Bacterial Vaginosis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Meningitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Meningitis. Report includes ... Read More
-
Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Report includes ... Read More
-
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Ventilator Associated Pneumonia (VAP) Clinical trials scenario. This report provides top line data ... Read More
-
Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication (Pain Management, Oncology, CNS Condition, Diabetes, Obesity), By Region, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed ... Read More
-
Osteoporosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update"" provides an overview of Osteoporosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoporosis. Report includes ... Read More
-
Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 123,000 diagnosed prevalent cases of Dravet syndrome across 16 pharmaceutical markets. Two FDA-approved branded marketed drugs are available for the treatment of Dravet syndrome. The Dravet syndrome pipeline ... Read More
-
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Opium (Opioid) Addiction Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Open-Angle Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Updateprovides an overview of Pancreatitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatitis. Report includes an ... Read More
-
Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Social Anxiety Disorder (SAD Social Phobia) Clinical trials scenario. ... Read More
-
Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... increased risk of chronic obstructive pulmonary disorder (COPD), hepatic failure, skin problems (panniculitis), and inflammation of the blood vessels (vasculitis). The current treatment options for AATD are alpha-1 proteinase inhibitor (A1-PI) therapies, which provide the ... Read More
-
Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Areas (Respiratory System, Oncology, Others), By Age Group, By Region, And Segment Forecasts, 2022 - 2030
... period, according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting ... Read More
-
Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Services (Clinical Trial Design And Consultation Services, Reading And Analytical Services), By End Use, By Application, By Region, And Segment Forecasts, 2022 - 2030
... Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine ... Read More
-
Clinical Trials Site Management Organizations Market Size, Share & Trends Analysis Report By Clinical Trail Services/Components, By Phase, By Therapeutic Areas (Oncology, Cardiology, CNS), By Region, And Segment Forecasts, 2022 - 2030
... Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the ... Read More
-
Clinical Trials Matching Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web & Cloud Based, On-premise), By End Use, By Region, And Segment Forecasts, 2022 - 2030
... It is expected to expand at a CAGR of 13.8% from 2022 to 2030. The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption ... Read More
-
Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2022 - 2030
... Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the ... Read More
Research Assistance
